- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-MyoAAV 1A Rep-Cap plasmid (serotype MyoAAV 1A - specific AAV RC-MyoAAV 1A plasmids) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi's MyoAAV 1A Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the MyoAAV 1A capsid protein.
You can produce MyoAAV 1A particle in 293T cell line in high titer using GeneMedi's MyoAAV 1A Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
MyoAAV1A is designed for efficient targeting and transduction of muscle cells. It likely incorporates specific modifications to the AAV1 capsid or uses muscle-specific promoters to enhance its affinity for skeletal and cardiac muscle tissues. This variant may be particularly useful for diseases where localized muscle gene therapy is required.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids.
Go to AAV
vector system
>>
Manual
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-RC30 | AAV-MyoAAV 1A Rep-Cap Plasmid (Amp resistance) Size：5ug | Academic | 2062 | ||
| P-RC30 | AAV-MyoAAV 1A Rep-Cap Plasmid (Amp resistance) Size：5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-RC30 | AAV-MyoAAV 1A Rep-Cap Plasmid (Amp resistance) Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC30 | AAV-MyoAAV 1A Rep-Cap Plasmid (Amp resistance) Size：≥10mg |
All | |||
| P-RC30-Kan | AAV-MyoAAV 1A Rep-Cap Plasmid (Kan resistance) Size：≥10mg |
All | |||
| P-PK30 | AAV-MyoAAV 1A Vector
System (Amp resistance)
1. MyoAAV 1A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug |
Academic | 3379 | ||
| P-PK30 | AAV-MyoAAV 1A Vector
System (Amp resistance)
1. MyoAAV 1A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-PK30 | AAV-MyoAAV 1A Vector
System (Amp resistance)
1. MyoAAV 1A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK30 | AAV-MyoAAV 1A Vector
System (Amp resistance)
1. MyoAAV 1A Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK30-Kan | AAV-MyoAAV 1A Vector
System(Kan resistance)
1. MyoAAV 1A Rep-Cap Plasmid(Kan resistance), ≥10mg 2. AAV Helper Plasmid(Kan resistance), ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Rep-Cap Plasmid. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Rep-Cap Plasmid currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries | Circulation | 2023/1/10 |
| Transcriptional switch of hepatocytes initiates macrophage recruitment and T cell suppression in endotoxemia | Journal of Hepatology | 2022/2/28 |
| Local delivery of EGFR+ NSCs-derived exosomes promotes neural regeneration post spinal cord injury via miR-34a-5p/HDAC6 pathway | Bioactive Materials | 2023/11/28 |
| From Phenomenon to Essence: A Newly Involved lncRNA Kcnq1ot1 Protective Mechanism of Bone Marrow Mesenchymal Stromal Cells in Liver Cirrhosis | Advanced Science | 2023/6/6 |
| RNA m6A methylation modulates airway inflammation in allergic asthma via PTX3-dependent macrophage homeostasis | Nature Communications | 2023/11/13 |
| [PDF] Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT | Advanced Science | 2023/10/22 |
| MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes | The Journal of Clinical Investigation | 2015/10/5 |
| CYP2S1 is a synthetic lethal target in BRAFV600E-driven thyroid cancers | Signal Transduction and Targeted Therapy | 2020/9/11 |
| Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy | Journal of Advanced Research | 2023/7/25 |
| TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1 | experimental and molecular medicine | 2023/6/1 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
